Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression

OBJECTIVE: There is an urgent need to assess the impact of immunosuppressive therapies on the immunogenicity and efficacy of SARS-CoV-2 vaccination. METHODS: Serological and T-cell ELISpot assays were used to assess the response to first-dose and second-dose SARS-CoV-2 vaccine (with either BNT162b2...

Descripción completa

Detalles Bibliográficos
Autores principales: Prendecki, Maria, Clarke, Candice, Edwards, Helena, McIntyre, Stacey, Mortimer, Paige, Gleeson, Sarah, Martin, Paul, Thomson, Tina, Randell, Paul, Shah, Anand, Singanayagam, Aran, Lightstone, Liz, Cox, Alison, Kelleher, Peter, Willicombe, Michelle, McAdoo, Stephen P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350975/
https://www.ncbi.nlm.nih.gov/pubmed/34362747
http://dx.doi.org/10.1136/annrheumdis-2021-220626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350975/
https://www.ncbi.nlm.nih.gov/pubmed/34362747
http://dx.doi.org/10.1136/annrheumdis-2021-220626

Ejemplares similares